State of Wyoming acquired a new stake in shares of Accendra Health, Inc. (NYSE:ACH – Free Report) in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm acquired 168,850 shares of the company’s stock, valued at approximately $385,000.
Other hedge funds have also recently modified their holdings of the company. Strs Ohio purchased a new stake in shares of Accendra Health in the 1st quarter worth about $413,000. Bank of New York Mellon Corp bought a new stake in Accendra Health during the first quarter worth about $592,000. Dimensional Fund Advisors LP bought a new stake in Accendra Health during the first quarter worth about $5,943,000. Hsbc Holdings PLC purchased a new stake in Accendra Health in the first quarter worth about $34,000. Finally, Allspring Global Investments Holdings LLC bought a new position in shares of Accendra Health during the first quarter valued at approximately $239,000.
Analyst Ratings Changes
A number of brokerages have recently commented on ACH. Zacks Research raised Accendra Health from a “strong sell” rating to a “hold” rating in a research report on Tuesday, April 21st. UBS Group increased their target price on Accendra Health from $3.00 to $4.50 and gave the stock a “neutral” rating in a research note on Tuesday, May 12th. Robert W. Baird boosted their price objective on shares of Accendra Health from $5.00 to $6.00 and gave the stock an “outperform” rating in a report on Tuesday, May 12th. Weiss Ratings upgraded Accendra Health from a “sell (e+)” rating to a “sell (d-)” rating in a research note on Tuesday, July 21st. Finally, Citigroup lowered their price target on Accendra Health from $5.00 to $4.50 and set a “buy” rating on the stock in a report on Friday. Two analysts have rated the stock with a Buy rating, two have assigned a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat.com, Accendra Health currently has a consensus rating of “Hold” and an average target price of $5.00.
Accendra Health Stock Down 0.3%
Shares of ACH stock opened at $3.13 on Monday. Accendra Health, Inc. has a 12-month low of $1.84 and a 12-month high of $7.99. The stock has a market capitalization of $239.70 million, a PE ratio of -0.22, a P/E/G ratio of 4.84 and a beta of 1.58. The stock has a 50 day moving average of $3.12.
Accendra Health (NYSE:ACH – Get Free Report) last announced its earnings results on Monday, May 11th. The company reported ($0.04) earnings per share for the quarter, beating analysts’ consensus estimates of ($0.06) by $0.02. The business had revenue of $627.78 million during the quarter. Accendra Health had a negative net margin of 39.84% and a negative return on equity of 13.18%. On average, analysts predict that Accendra Health, Inc. will post 0.31 EPS for the current year.
Accendra Health Profile
Accendra Health Inc is a nationwide provider of products, technology, and services that support health beyond the hospital by connecting patients, providers, and insurers. Through its brands, Apria and Byram Healthcare, the company delivers disposable medical supplies, integrated home healthcare equipment, and related services that help improve health outcomes and quality of life for individuals with chronic, complex, and acute health conditions. Its offerings span diabetes treatment, home respiratory therapy, and obstructive sleep apnea treatment, along with patient support services.
Recommended Stories
- Five stocks we like better than Accendra Health
- RTX and Lockheed Earnings: Can Strong Guidance Reset the Defense Trade?
- These 4 Earnings Reports Expose the Market’s Growing Economic Divide
- Broadcom May Be the Biggest Winner From Alphabet’s Earnings
- Volatility Is Back and These 3 Market Tollbooths Are Best Positioned to Profit
Want to see what other hedge funds are holding ACH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Accendra Health, Inc. (NYSE:ACH – Free Report).
Receive News & Ratings for Accendra Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Accendra Health and related companies with MarketBeat.com's FREE daily email newsletter.
